Analysts await Curis, Inc. (NASDAQ:CRIS) to report earnings on May, 09 for the fiscal quarter ending Mar 2016.

They expect $-0.08 EPS, down 12.5% or $0.01 from last year’s $-0.07 per share.

At the moment 6 analysts are watching Curis, Inc. (NASDAQ:CRIS), 2 rate it “Buy”, 4 “Outperform”, 0 “Underperform”, 0 “Sell”, while 0 “Hold”.

Looking forward, for the quarter ending Jun-16, 6 analysts have a mean sales target of 2.39 million. For the quarter ending Sep-16, 6 analysts have a mean sales target of 2.64 million whilst for the year ending Dec-16, 6 analysts have a mean target of 10.41 million.

In terms of earnings per share, 6 analysts have a -0.08 EPS mean target for the quarter ending Jun-16, for the quarter ending Sep-16, 6 analysts have a -0.09 EPS mean target and for the quarter ending Sep-16 there are 6 estimates of -0.33 EPS.

The biggest institutional shareholders in Curis, Inc. include Arnhold & S. Bleichroeder Advisers, LLC which owns 24 million shares in the company valued at $69.87 million. Fidelity Management and Research Company is the second biggest holder with 19 million shares currently valued at 56.04 million whilst Dr Reddy Laboratories Ltd has 17 million shares valued at 25.68 million.

Total shares held by institutions as of the most recent company filings are 86,367,342 with a reported 5,450,894 bought and 2,654,351 sold. These holdings make up 66.97% of the company’s outstanding shares.

Currently insiders hold 1,248,528 shares in the business which makes up 0.97% of shares. The biggest holder currently is James R. Mcnab,Jr who owns 1,049,688 shares (0.81% of those outstanding), whilst Daniel R. Passeri holds 211,798 (0.16% of shares outstanding) and Douglas A. Melton,PhD holds 173,499 (0.13% of shares outstanding).

The stock increased 0.00% or $0 during the last trading session.